New developments in the pathology of malignant lymphoma: a review of the literature published from January to August 2009

1.

Lim MS, de Leval L, Quintanilla-Martinez L (2009) Commentary on the 2008 WHO classification of mature T- and NK-cell neoplasms. J Hematop 2:65–73CrossRef

2.

Lim MS (2009) Commentary on the WHO 2008 classification of neoplasms arising from histiocytic and other accessory cells. J Hematop 2:75–76CrossRefPubMed

3.

Ott G, Balague-Ponz O, de Leval L, de Jong D, asserjian RP, Elenitoba-Johnson KS (2009) Commentary on the WHO classification of tumors of lymphoid tissues (2008): indolent B cell lymphomas. J Hematop 2:77–81CrossRef

4.

Balague Ponz O, Ott G, Hasserjian RP, Elenitoba-Johnson KS, de Leval L, de Jong D (2009) Commentary on the WHO classification of tumors of lymphoid tissues (2008): aggressive B cell lymphomas. J Hematop 2:83–87CrossRef

5.

Hasserjian RP, Ott G, Elenitoba-Johnson KS, Balague-Ponz O, de Jong D, de Leval L (2009) Commentary on the WHO classification of tumors of lymphoid tissues (2008): “gray zone” lymphomas overlapping with Burkitt lymphoma or classical Hodgkin lymphoma. J Hematop 2:89–95CrossRef

6.

van der Walt J (2009) Recent advances in bone marrow biopsy pathology. J Hematop 2:97–102CrossRef

7.

van Krieken JH (2008) New developments in the pathology of malignant lymphoma: a review of the literature published from January to April 2008. J Hematop 1:37–45CrossRefPubMed

8.

van Krieken JH (2008) New developments in the pathology of malignant lymphoma: a review of the literature published from May to July 2008. J Hematop 1:145–160CrossRefPubMed

9.

van Krieken JH (2009) New developments in the pathology of malignant lymphoma: a review of the literature published from August to December 2008. J Hematop 2:50–61CrossRef

10.

Huang T, Shenoy PJ, Sinha R, Graiser M, Bumpers KW, Flowers CR (2009) Development of the lymphoma enterprise architecture database: a caBIG(tm) silver levelcompliant system. Cancer Inform 8:45–64PubMed

11.

Anastasov N, Klier M, Koch I, Angermeier D, Höfler H, Fend F, Quintanilla-Martinez L (2009) Efficient shRNA delivery into B and T lymphoma cells using lentiviral vector-mediated transfer. J Hematop 1:9–19CrossRef

12.

Hartlapp I, Pallasch C, Weibert G, Kemkers A, Hummel M, Re D (2009) Depsipeptide induces cell death in Hodgkin lymphoma-derived cell lines. Leuk Res 33:929–936CrossRefPubMed

13.

Jones RJ, Gocke CD, Kasamon YL, Miller CB, Perkins B, Barber JP, Vala MS, Gerber JM, Gellert LL, Siedner M, Lemas MV, Brennan S, Ambinder RF, Matsui W (2009) Circulating clonotypic B cells in classic Hodgkin lymphoma. Blood 113:5920–5926CrossRefPubMed

14.

Maby-El Hajjami H, Amé-Thomas P, Pangault C, Tribut O, DeVos J, Jean R, Bescher N, Monvoisin C, Dulong J, Lamy T, Fest T, Tarte K (2009) Functional alteration of the lymphoma stromal cell niche by the cytokine context: role of indoleamine-2, 3 dioxygenase. Cancer Res 69:3228–3237CrossRefPubMed

15.

Yang ZZ, Novak AJ, Ziesmer SC, Witzig TE, Ansell SM (2009) Malignant B cells skew the balance of regulatory T cells and TH17 cells in B-cell non-Hodgkin's lymphoma. Cancer Res 69:5522–5523CrossRefPubMed

16.

Kurtova AV, Tamayo AT, Ford RJ, Burger JA (2009) Mantle cell lymphoma cells express high levels of CXCR4, CXCR5, and VLA-4 (CD49d): importance for interactions with the stromal microenvironment and specific targeting. Blood 113:4604–4613CrossRefPubMed

17.

Krejsgaard T, Vetter-Kauczok CS, Woetmann A, Kneitz H, Eriksen KW, Lovato P, Zhang Q, Wasik MA, Geisler C, Ralfkiaer E, Becker JC, Ødum N (2009) Ectopic expression of B-lymphoid kinase in cutaneous T-cell lymphoma. Blood 113:5896–5904CrossRefPubMed

18.

Rossi EA, Goldenberg DM, Cardillo TM, Stein R, Chang CH (2009) Hexavalent bispecific antibodies represent a new class of anticancer therapeutics: 1. Properties of anti-CD20/CD22 antibodies in lymphoma. Blood 113:6161–6171CrossRefPubMed

19.

Bahler DW, Szankasi P, Kulkarni S, Tubbs RR, Cook JR, Swerdlow SH (2009) Use of similar immunoglobulin VH gene segments by MALT lymphomas of the ocular adnexa. Mod Pathol 22:833–838PubMed

20.

Novak U, Rinaldi A, Kwee I, Nandula SV, Rancoita PM, Compagno M, Cerri M, Rossi D, Murty VV, Zucca E, Gaidano G, Dalla-Favera R, Pasqualucci L, Bhagat G, Bertoni F (2009) The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas. Blood 113:4918–4921CrossRefPubMed

21.

Wang M, Atayar C, Rosati S, Bosga-Bouwer A, Kluin P, Visser L (2009) JNK is constitutively active in mantle cell lymphoma: cell cycle deregulation and polyploidy by JNK inhibitor SP600125. J Pathol 218:95–103CrossRefPubMed

22.

Bennett LB, Schnabel JL, Kelchen JM, Taylor KH, Guo J, Arthur GL, Papageorgio CN, Shi H, Caldwell CW (2009) DNA hypermethylation accompanied by transcriptional repression in follicular lymphoma. Genes Chromosomes Cancer 48:828–841CrossRefPubMed

23.

Kondo T, Oka T, Sato H, Shinnou Y, Washio K, Takano M, Morito T, Takata K, Ohara N, Ouchida M, Shimizu K, Yoshino T (2009) Accumulation of aberrant CpG hypermethylation by Helicobacter pylori infection promotes development and progression of gastric MALT lymphoma. Int J Oncol 35:547–557PubMed

24.

Gelebart P, Zak Z, Anand M, Dien-Bard J, Amin HM, Lai R. Interleukin-21 effectively induces apoptosis in mantle cell lymphoma through a STAT1-dependent mechanism. Leukemia (2009). doi:10.1038/leu.2009.100

25.

Saito M, Novak U, Piovan E, Basso K, Sumazin P, Schneider C, Crespo M, Shen Q, Bhagat G, Califano A, Chadburn A, Pasqualucci L, Dalla-Favera R (2009) BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma. Proc Natl Acad Sci USA 106:11294–11299CrossRefPubMed

26.

Leucci E, Onnis A, Cocco M, De Falco G, Imperatore F, Antonicelli G, Costanzo, Cerino G, Mannucci S, Cantisani R, Nyagol J, Mwanda W, Iriso R, Owang M, Schurfeld K, Bellan C, Lazzi S, Leoncini L (2009) B cell differentiation in EBV-positive Burkitt Lymphoma is impaired at post-transcriptional level by miRNA altered expression. Int J Cancer. Jun 15 (in press)

27.

Meier C, Hoeller S, Bourgau C, Hirschmann P, Schwaller J, Went P, Pileri SA, Reiter A, Dirnhofer S, Tzankov A (2009) Recurrent numerical aberrations of JAK2 and deregulation of the JAK2-STAT cascade in lymphomas. Mod Pathol 22:476–487CrossRefPubMed

28.

Mathas S, Kreher S, Meaburn KJ, Jöhrens K, Lamprecht B, Assaf C, Sterry W, Kadin ME, Daibata M, Joos S, Hummel M, Stein H, Janz M, Anagnostopoulos I, Schrock E, Misteli T, Dörken B (2009) Gene deregulation and spatial genome reorganization near breakpoints prior to formation of translocations in anaplastic large cell lymphoma. Proc Natl Acad Sci USA 106:5831–5836CrossRefPubMed

29.

Lim MS, Carlson ML, Crockett DK, Fillmore GC, Abbott DR, Elenitoba-Johnson OF, Tripp SR, Rassidakis GZ, Medeiros LJ, Szankasi P, Elenitoba-Johnson KS (2009) The proteomic signature of NPM/ALK reveals deregulation of multiple cellular pathways. Blood 114(8):1,585–1595CrossRef

30.

Singh RR, Cho-Vega JH, Davuluri Y, Ma S, Kasbidi F, Milito C, Lennon PA, Drakos E, Medeiros LJ, Luthra R, Vega F (2009) Sonic hedgehog signaling pathway is activated in ALK-positive anaplastic large cell lymphoma. Cancer Res 69:2550–2558CrossRefPubMed

31.

Dien Bard J, Gelebart P, Anand M, Zak Z, Hegazy SA, Amin HM, Lai R (2009) IL-21 contributes to JAK3/STAT3 activation and promotes cell growth in ALK-positive anaplastic large cell lymphoma. Am J Pathol 175:825–834CrossRefPubMed

32.

Bobos M, Kotoula V, Kaloutsi V, Karayannopoulou G, Papadimitriou CS, Kostopoulos I (2009) Aberrant CCND1 copies and cyclin D1 mRNA expression do not result in the production of functional cyclin D1 protein in anaplastic large cell lymphoma. Histol Histopathol 24:1035–1048PubMed

33.

Toracchio S, Kozinetz CA, Killen DE, Sheehan AM, Banez EI, Ittmann MM, Sroller V, Butel JS (2009) Variable frequency of polyomavirus SV40 and herpesvirus EBV in lymphomas from two different urban population groups in Houston, TX. J Clin Virol. 46(2):154–160CrossRefPubMed

34.

Chen W, Huang Q, Zuppan CW, Rowsell EH, Cao JD, Weiss LM, Wang J (2009) Complete absence of KSHV/HHV-8 in posttransplant lymphoproliferative disorders: an immunohistochemical and molecular study of 52 cases. Am J Clin Pathol 131:632–639CrossRefPubMed

35.

Morton LM, Purdue MP, Zheng T, Wang SS, Armstrong B, Zhang Y, Menashe I, Chatterjee N, Davis S, Lan Q, Vajdic CM, Severson RK, Holford TR, Kricker A, Cerhan JR, Leaderer B, Grulich A, Yeager M, Cozen W, Hoar Zahm S, Chanock SJ, Rothman N, Hartge P (2009) Risk of non-Hodgkin lymphoma associated with germline variation in genes that regulate the cell cycle, apoptosis, and lymphocyte development. Cancer Epidemiol Biomarkers Prev 18:1259–1270CrossRefPubMed

36.

Irons RD, Le A, Bao L, Zhu X, Ryder J, Wang XQ, Ji M, Chen Y, Wu X, Lin G (2009) Characterization of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) in Changhai, China: Molecular and cytogenetic characteristics, IgV gene restriction and hypermutation patterns. Leuk Res (in press)

37.

Nam-Cha SH, Montes-Moreno S, Salcedo MT, Sanjuan J, Garcia JF, Piris MA (2009) Lymphocyte-rich classical Hodgkin's lymphoma: distinctive tumor and microenvironment markers. Mod Pathol 22:1006–1015CrossRefPubMed

38.

Bhargava P, Pantanowitz L, Pinkus GS, Pinkus JL, Paessler ME, Roullet M, Gautam S, Bagg A, Kadin ME (2009) Utility of Fascin and JunB in Distinguishing Nodular Lymphocyte Predominant From Classical Lymphocyte-rich Hodgkin Lymphoma. Appl Immunohistochem Mol Morphol (in press)

39.

Slack GW, Ferry JA, Hasserjian RP, Sohani AR, Longtine JA, Harris NL, Zukerberg LR (2009) Lymphocyte depleted Hodgkin lymphoma: an evaluation with immunophenotyping and genetic analysis. Leuk Lymphoma 50:937–943CrossRefPubMed

40.

Schraders M, van Reijmersdal SV, Kamping EJ, van Krieken JH, van Kessel AG, Groenen PJ, Hoogerbrugge PM, Kuiper RP (2009) High-resolution genomic profiling of pediatric lymphoblastic lymphomas reveals subtle differences with pediatric acute lymphoblastic leukemias in the B-lineage. Cancer Genet Cytogenet 191:27–33CrossRefPubMed

41.

Schniederjan SD, Osunkoya AO (2009) Lymphoid neoplasms of the urinary tract and male genital organs: a clinicopathological study of 40 cases. Mod Pathol 22:1057–1065CrossRefPubMed

42.

Validire P, Capovilla M, Asselain B, Kirova Y, Goudefroye R, Plancher C, Fourquet A, Zanni M, Gaulard P, Vincent-Salomon A, Decaudin D (2009) Primary breast non-Hodgkin's lymphoma: a large single center study of initial characteristics, natural history, and prognostic factors. Am J Hematol 84:133–139CrossRefPubMed

43.

Mozos A, Ye H, Chuang WY, Chu JS, Huang WT, Chen HK, Hsu YH, Bacon CM, Du MQ, Campo E, Chuang SS (2009) Most primary adrenal lymphomas are diffuse large B-cell lymphomas with non-germinal center B-cell phenotype, BCL6 gene rearrangement and poor prognosis. Mod Pathol (in press)

44.

Yin CC, Lin KI, Ketterling RP, Knudson RA, Medeiros LJ, Barron LL, Huh YO, Luthra R, Keating MJ, Abruzzo LV (2009) Chronic lymphocytic leukemia With t(2;14)(p16;q32) involves the BCL11A and IgH genes and is associated with atypical morphologic features and unmutated IgVH genes. Am J Clin Pathol 131:663CrossRefPubMed

45.

Dong HY, Weisberger J, Liu Z, Tugulea S (2009) Immunophenotypic analysis of CD103+ B-lymphoproliferative disorders: hairy cell leukemia and its mimics. Am J Clin Pathol 131:586–595CrossRefPubMed

46.

Robertus JL, Harms G, Blokzijl T, Booman M, de Jong D, van Imhoff G, Rosati S, Schuuring E, Kluin P, van den Berg A (2009) Specific expression of miR-17–5p and miR-127 in testicular and central nervous system diffuse large B-cell lymphoma. Mod Pathol 22:547–555CrossRefPubMed

47.

Schraders M, Oeschger S, Kluin PM, Hebeda K, Schuuring E, Groenen PJ, Hansmann ML, van Krieken JH (2009) Hypermutation in mantle cell lymphoma does not indicate a clinical or biological subentity. Mod Pathol 22:416–425CrossRefPubMed

48.

Toracchio S, Ota H, de Jong D, Wotherspoon A, Rugge M, Graham DY, Samani A, El-Zimaity HM (2009) Translocation t(11;18)(q21;q21) in gastric B-cell lymphomas. Cancer Sci 100:881–887CrossRefPubMed

49.

Kanellis G, Roncador G, Arribas A, Mollejo M, Montes-Moreno S, Maestre L, Campos-Martin Y, Ríos Gonzalez JL, Martinez-Torrecuadrada JL, Sanchez-Verde L, Pajares R, Cigudosa JC, Martin MC, Piris MA (2009) Identification of MNDA as a new marker for nodal marginal zone lymphoma. Leukemia (in press)

50.

Leich E, Salaverria I, Bea S, Zettl A, Wright G, Moreno V, Gascoyne RD, Chan WC, Braziel RM, Rimsza LM, Weisenburger DD, Delabie J, Jaffe ES, Lister A, Fitzgibbon J, Staudt LM, Hartmann EM, Mueller-Hermelink HK, Campo E, Ott G, Rosenwald A (2009) Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations. Blood 114:826–834CrossRefPubMed

51.

Gu K, Fu K, Jain S, Liu Z, Iqbal J, Li M, Sanger WG, Weisenburger DD, Greiner TC, Aoun P, Dave BJ, Chan WC (2009) t(14;18)-negative follicular lymphomas are associated with a high frequency of BCL6 rearrangement at the alternative breakpoint region. Mod Pathol. [Epub ahead of print]

52.

Howard MT, Dufresne S, Swerdlow SH, Cook JR (2009) Follicular lymphoma of the spleen: multiparameter analysis of 16 cases. Am J Clin Pathol 131:656–662CrossRefPubMed

53.

Mollejo M, Rodríguez-Pinilla MS, Montes-Moreno S, Algara P, Dogan A, Cigudosa JC, Juarez R, Flores T, Forteza J, Arribas A, Piris MA (2009) Splenic follicular lymphoma: clinicopathologic characteristics of a series of 32 cases. Am J Surg Pathol 33:730–738CrossRefPubMed

54.

Obermann EC, Csato M, Dirnhofer S, Tzankov A (2009) Aberrations of the MYC gene in unselected cases of diffuse large B-cell lymphoma are rare and unpredictable by morphological or immunohistochemical assessment. J Clin Pathol 62:754–756CrossRefPubMed

55.

Molina-Privado I, Rodríguez-Martínez M, Rebollo P, Martín-Pérez D, Artiga MJ, Menárguez J, Flemington EK, Piris MA, Campanero MR (2009) E2F1 expression is deregulated and plays an oncogenic role in sporadic Burkitt's lymphoma. Cancer Res 69:4052–4058CrossRefPubMed

56.

Korać P, Peran I, Skrtić A, Ajduković R, Kristo DR, Dominis M (2009) FOXP1 expression in monoclonal gammopathy of undetermined significance and multiple myeloma. Pathol Int 59:354–358CrossRefPubMed

57.

Verbeek WH, von Blomberg BM, Coupe VM, Daum S, Mulder CJ, Schreurs MW, Aberrant (2009) T-lymphocytes in refractory coeliac disease are not strictly confined to a small intestinal intraepithelial localization. Cytometry B Clin Cytom (in press)

58.

Cho YU, Chi HS, Park CJ, Jang S, Seo EJ, Huh J (2009) Distinct features of angioimmunoblastic T-cell lymphoma with bone marrow involvement. Am J Clin Pathol 131:640–646CrossRefPubMed

59.

Huang Y, Moreau A, Dupuis J, Streubel B, Petit B, Le Gouill S, Martin-Garcia N, Copie-Bergman C, Gaillard F, Qubaja M, Fabiani B, Roncador G, Haioun C, Delfau-Larue MH, Marafioti T, Chott A, Gaulard P (2009) Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomas. Am J Surg Pathol 33:682–690CrossRefPubMed

60.

Falchook GS, Vega F, Dang NH, Samaniego F, Rodriguez MA, Champlin RE, Hosing C, Verstovsek S, Pro B (2009) Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment. Ann Oncol 20:1080–1085CrossRefPubMed

61.

Shaw GR, Naik VS (2008) The gammadelta variant of T cell large granular lymphocyte leukemia is very similar to the common alphabeta type: report of two cases. J Hematop 1:139–143CrossRefPubMed

62.

Buxton D, Bacchi CE, Gualco G, Weiss LM, Zuppan CW, Rowsell EH, Huang Q, Wang J (2009) Frequent expression of CD99 in anaplastic large cell lymphoma: a clinicopathologic and immunohistochemical study of 160 cases. Am J Clin Pathol 131:574–579CrossRefPubMed

63.

Beltraminelli H, Leinweber B, Kerl H, Cerroni L (2009) Primary cutaneous CD4+ small-/medium-sized pleomorphic T-cell lymphoma: a cutaneous nodular proliferation of pleomorphic T lymphocytes of undetermined significance? A study of 136 cases. Am J Dermatopathol 31:317–322CrossRefPubMed

64.

Sato Y, Kojima M, Takata K, Morito T, Asaoku H, Takeuchi T, Mizobuchi K, Fujihara M, Kuraoka K, Nakai T, Ichimura K, Tanaka T, Tamura M, Nishikawa Y, Yoshino T (2009) Systemic IgG4-related lymphadenopathy: a clinical and pathologic comparison to multicentric Castleman's disease. Mod Pathol 22:589–599CrossRefPubMed

65.

Chen D, Law ME, Theis JD, Gamez JD, Caron LB, Vrana JA, Dogan A (2009) Clinicopathologic features of CDK6 translocation-associated B-cell lymphoproliferative disorders. Am J Surg Pathol 33:720–729CrossRefPubMed

66.

Gibson SE, Hsi ED (2009) Epstein-Barr virus-positive B-cell lymphoma of the elderly at a United States tertiary medical center: an uncommon aggressive lymphoma with a nongerminal center B-cell phenotype. Hum Pathol 40:653–661CrossRefPubMed

67.

Maeshima AM, Taniguchi H, Nomoto J, Maruyama D, Kim SW, Watanabe T, Kobayashi Y, Tobinai K, Matsuno Y (2009) Secondary CD5+ diffuse large B-cell lymphoma not associated with transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma (Richter syndrome). Am J Clin Pathol 131:339–346CrossRefPubMed

68.

Hatanaka K, Nakamura N, Kojima M, Ando K, Irie S, Bunno M, Nakamine H, Uekusa T (2009) Methotrexate-associated lymphoproliferative disorders mimicking angioimmunoblastic T-cell lymphoma. Pathol Res Pract (in press)

69.

Dunleavy K, Pittaluga S, Czuczman MS, Dave SS, Wright G, Grant N, Shovlin M, Jaffe ES, Janik JE, Staudt LM, Wilson WH (2009) Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma. Blood 113:6069–6076CrossRefPubMed

70.

Jiang L, Yuan CM, Hubacheck J, Janik JE, Wilson W, Morris JC, Jasper GA, Stetler-Stevenson M (2009) Variable CD52 expression in mature T cell and NK cell malignancies: implications for alemtuzumab therapy. Br J Haematol 145:173–179CrossRefPubMed

71.

Troncone G, Guerriero E, Pallante P, Berlingieri MT, Ferraro A, Del Vecchio L, Gorrese M, Mariotti E, Iaccarino A, Palmieri EA, Zeppa P, Palombini L, Fusco A (2009) UbcH10 expression in human lymphomas. Histopathology 54:731–740CrossRefPubMed

72.

Marquard L, Poulsen CB, Gjerdrum LM, de Nully Brown P, Christensen IJ, Jensen PB, Sehested M, Johansen P, Ralfkiaer E (2009) Histone deacetylase 1, 2, 6 and acetylated histone H4 in B- and T-cell lymphomas. Histopathology 54:688–698CrossRefPubMed

73.

Diepstra A, van Imhoff GW, Schaapveld M, Karim-Kos H, van den Berg A, Vellenga E, Poppema S (2009) Latent Epstein-Barr virus infection of tumor cells in classical Hodgkin's lymphoma predicts adverse outcome in older adult patients. J Clin Oncol 27:3815–3821CrossRefPubMed

74.

Johnson NA, Leach S, Woolcock B, deLeeuw RJ, Bashashati A, Sehn LH, Connors JM, Chhanabhai M, Brooks-Wilson A, Gascoyne RD (2009) CD20 mutations involving the rituximab epitope are rare in diffuse large B-cell lymphomas and are not a significant cause of R-CHOP failure. Haematologica 94:423–427CrossRefPubMed

75.

Sánchez-Espiridión B, Sánchez-Aguilera A, Montalbán C, Martin C, Martinez R, González-Carrero J, Poderos C, Bellas C, Fresno MF, Morante C, Mestre MJ, Mendez M, Mazorra F, Conde E, Castaño A, Sánchez-Godoy P, Tomas JF, Morente MM, Piris MA, García JF (2009) Spanish Hodgkin's Lymphoma Study Group. A TaqMan low-density array to predict outcome in advanced Hodgkin's lymphoma using paraffin-embedded samples. Clin Cancer Res 15:1367–1375CrossRefPubMed

76.

Canioni D, Deau-Fischer B, Taupin P, Ribrag V, Delarue R, Bosq J, Rubio MT, Roux D, Vasiliu V, Varet B, Brousse N, Hermine O (2009) Prognostic significance of new immunohistochemical markers in refractory classical Hodgkin lymphoma: a study of 59 cases. PLoS One 4:e6341CrossRefPubMed

77.

Bhagavathi S, Gu K, Loberiza FR, Bast M, Vose JM, Weisenburger DD (2009) Does a diffuse growth pattern predict for survival in patients with low-grade follicular lymphoma? Leuk Lymphoma 50:900–903CrossRefPubMed

78.

Carreras J, Lopez-Guillermo A, Roncador G, Villamor N, Colomo L, Martinez A, Hamoudi R, Howat WJ, Montserrat E, Campo E (2009) High numbers of tumor-infiltrating programmed cell death 1-positive regulatory lymphocytes are associated with improved overall survival in follicular lymphoma. J Clin Oncol 27:1470–1476CrossRefPubMed

79.

Koster A, Tromp HA, Raemaekers JM, Borm GF, Hebeda K, Mackenzie MA, van Krieken JH (2007) The prognostic significance of the intra-follicular tumor cell proliferative rate in follicular lymphoma. Haematologica 92:184–190CrossRefPubMed

80.

Koster A, van Krieken JH, Mackenzie MA, Schraders M, Borm GF, van der Laak JA, Leenders W, Hebeda K, Raemaekers JM (2005) Increased vascularization predicts favorable outcome in follicular lymphoma. Clin Cancer Res 11:154–161PubMed

81.

Han SL, Wu XL, Wan L, Zeng QQ, Li JL, Liu Z (2009) FOXP1 expression predicts polymorphic histology and poor prognosis in gastric mucosa-associated lymphoid tissue lymphomas. Dig Surg 26:156–162CrossRefPubMed

82.

Sumida T, Kitadai Y, Hiyama T, Shinagawa K, Tanaka M, Kodama M, Masuda H, Ito M, Tanaka S, Yoshihara M, Chayama K (2009) Antibodies to Helicobacter pylori and CagA protein are associated with the response to antibacterial therapy in patients with H. pylori-positive API2-MALT1-negative gastric MALT lymphoma. Cancer Sci 100:1075–1081CrossRefPubMed

83.

Ilić I, Mitrović Z, Aurer I, Basić-Kinda S, Radman I, Ajduković R, Labar B, Dotlić S, Nola M (2009) Lack of prognostic significance of the germinal-center phenotype in diffuse large B-cell lymphoma patients treated with CHOP-like chemotherapy with and without rituximab. Int J Hematol 90:74–80CrossRefPubMed

84.

Morito T, Fujihara M, Asaoku H, Tari A, Sato Y, Ichimura K, Tanaka T, Takata K, Tamura M, Yoshino T (2009) Serum soluble interleukin-2 receptor level and immunophenotype are prognostic factors for patients with diffuse large B-cell lymphoma. Cancer Sci 100:1255–1260CrossRefPubMed

85.

Johnson NA, Savage KJ, Ludkovski O, Ben-Neriah S, Woods R, Steidl C, Dyer MJ,Siebert R, Kuruvilla J, Klasa R, Connors JM, Gascoyne RD, Horsman DE (2009) Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival. Blood (in press)

86.

Balague O, Mozos A, Martinez D, Hernandez L, Colomo L, Mate JL, Teruya-Feldstein J, Lin O, Campo E, Lopez-Guillermo A, Martinez A (2009) Activation of the endoplasmic reticulum stress-associated transcription factor x box-binding protein-1 occurs in a subset of normal germinal-center B cells and in aggressive B-cell lymphomas with prognostic implications. Am J Pathol 174:2337–2346CrossRefPubMed

87.

Soltani-Arabshahi R, Leboeuf C, Rivet J, Pisonero H, Zhao WL, Bachelez H, Ameisen JC, Janin A (2009) Bcl-xL gene expression correlated with lower apoptotic cell numbers and shorter progression-free survival in PCFCL. J Invest Dermatol 129:1703–1709CrossRefPubMed

88.

Curry CV, Ewton AA, Olsen RJ, Logan BR, Preti HA, Liu YC, Perkins SL, Chang CC (2009) Prognostic impact of C-REL expression in diffuse large B-cell lymphoma. J Hematop 2:20–26CrossRefPubMed

89.

Kim JE, Singh RR, Cho-Vega JH, Drakos E, Davuluri Y, Khokhar FA, Fayad L, Medeiros LJ, Vega F (2009) Sonic hedgehog signaling proteins and ATP-binding cassette G2 are aberrantly expressed in diffuse large B-Cell lymphoma. Mod Pathol (in press)

90.

Briones J, Moga E, Espinosa I, Vergara C, Alvarez E, Villa J, Bordes R, Delgado J, Prat J, Sierra J (2009) Bcl-10 protein highly correlates with the expression of phosphorylated p65 NF-kappaB in peripheral T-cell lymphomas and is associated with clinical outcome. Histopathology 54:478–485CrossRefPubMed

91.

Kim WY, Jeon YK, Kim TM, Kim JE, Kim YA, Lee SH, Kim DW, Heo DS, Kim CW (2009) Increased quantity of tumor-infiltrating FOXP3-positive regulatory T cells is an independent predictor for improved clinical outcome in extranodal NK/T-celllymphoma. Ann Oncol (in press)

92.

Vidulich KA, Talpur R, Bassett RL, Duvic M (2009) Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma. Int J Dermatol 48:243–252CrossRefPubMed

93.

Woo DK, Jones CR, Vanoli-Storz MN, Kohler S, Reddy S, Advani R, Hoppe RT, Kim YH (2009) Prognostic factors in primary cutaneous anaplastic large cell lymphoma:characterization of clinical subset with worse outcome. Arch Dermatol 145:667–674CrossRefPubMed

94.

Chandra P, Plaza JA, Zuo Z, Diwan AH, Koeppen H, Duvic M, Medeiros LJ, Prieto VG (2009) Clusterin expression correlates with stage and presence of large cells in mycosis fungoides. Am J Clin Pathol 131:511–515CrossRefPubMed

95.

Quereux G, Frot AS, Brocard A, Leux C, Renaut JJ, Dreno B (2009) Routine bone marrow biopsy in the initial evaluation of primary cutaneous B-cell lymphoma does not appear justified. Eur J Dermatol 19:216–220PubMed

96.

Baiyee D, Warnke R, Natkunam Y (2009) Lack of utility of CD20 immunohistochemistry in staging bone marrow biopsies for diffuse large B-cell lymphoma. Appl Immunohistochem Mol Morphol 17:93–95CrossRefPubMed

97.

Ilgenfritz RB, Kayasut K, Le Tourneau A, Calendini OA, Ouafi L, Marzac C, Diebold J, Devez F, Ducruit V, Bouchet PE, Audouin J, Molina TJ (2009) Correlation between molecular and histopathological diagnoses of B cell lymphomas in bone marrow biopsy and aspirates. J Clin Pathol 62:357–360CrossRefPubMed

98.

Quijano S, López A, Manuel Sancho J, Panizo C, Debén G, Castilla C, Antonio García-Vela J, Salar A, Alonso-Vence N, González-Barca E, Peñalver FJ, Plaza-Villa J, Morado M, García-Marco J, Arias J, Briones J, Ferrer S, Capote J, Nicolás C, Orfao A (2009) Spanish Group for the Study of CNS Disease in NHL. Identification of leptomeningeal disease in aggressive B-cell non-Hodgkin's lymphoma: improved sensitivity of flow cytometry. J Clin Oncol 27:1462–1469CrossRefPubMed

99.

Wu JM, Georgy MF, Burroughs FH, Weir EG, Rosenthal DL, Ali SZ (2009) Lymphoma, leukemia, and pleiocytosis in cerebrospinal fluid: Is accurate cytopathologic diagnosis possible based on morphology alone? Diagn Cytopathol (in press)

100.

Das DK, Francis IM, Sharma PN, Sathar SA, John B, George SS, Mallik MK, Sheikh ZA, Haji BE, Pathan SK, Madda JP, Mirza K, Ahmed MS, Junaid TA (2009) Hodgkin's lymphoma: diagnostic difficulties in fine-needle aspiration cytology. Diagn Cytopathol 37:564–573CrossRefPubMed

101.

Demurtas A, Accinelli G, Pacchioni D, Godio L, Novero D, Bussolati G, Palestro G, Papotti M, Stacchini A (2009) Utility of Flow Cytometry Immunophenotyping in Fine-needle Aspirate Cytologic Diagnosis of Non-Hodgkin Lymphoma: A Series of 252 Cases and Review of the Literature. Appl Immunohistochem Mol Morphol (in press)

102.

Fromm JR, Thomas A, Wood BL (2009) Flow cytometry can diagnose classical Hodgkin lymphoma in lymph nodes with high sensitivity and specificity. Am J Clin Pathol 131:322–332CrossRefPubMed

103.

Sugita S, Takase H, Sugamoto Y, Arai A, Miura O, Mochizuki M (2009) Diagnosis of intraocular lymphoma by polymerase chain reaction analysis and cytokine profiling of the vitreous fluid. Jpn J Ophthalmol 53:209–214CrossRefPubMed

104.

Pantanelli SM, Li Z, Fariss R, Mahesh SP, Liu B, Nussenblatt RB (2009) Differentiation of malignant B-lymphoma cells from normal and activated T-cell populations by their intrinsic autofluorescence. Cancer Res 69:4911–4917CrossRefPubMed

105.

Fan HB, Zhu YF, Chen AS, Zhou MX, Yan FM, Ma XJ, Zhou H (2009) B-cell clonality in the liver of hepatitis C virus-infected patients. World J Gastroenterol 15:1636–1640CrossRefPubMed

106.

Hebeda KM, Van Altena MC, Rombout P, Van Krieken JH, Groenen PJ (2009) PCR clonality detection in Hodgkin lymphoma. J Hematop 2:34–41CrossRefPubMed

107.

Miguet L, Béchade G, Fornecker L, Zink E, Felden C, Gervais C, Herbrecht R, van Dorsselaer A, Mauvieux L, Sanglier-Cianferani S (2009) Proteomic analysis of malignant B-cell derived microparticles reveals CD148 as a potentially useful antigenic biomarker for mantle cell lymphoma diagnosis. J Proteome Res 8:3346–3354CrossRefPubMed

108.

Romesser PB, Perlman DH, Faller DV, Costello CE, McComb ME, Denis GV (2009) Development of a malignancy-associated proteomic signature for diffuse large B-cell lymphoma. Am J Pathol 175:25–35CrossRefPubMed

109.

Jansen C, Hebeda KM, Linkels M, Grefte JM, Raemaekers JM, van Krieken JH, Groenen PJ (2008) Protein profiling of B-cell lymphomas using tissue biopsies: A potential tool for small samples in pathology. Cell Oncol 30:27–38PubMed

At a glance: The STEP trials

Springer Medicine

New developments in the pathology of malignant lymphoma: a review of the literature published from January to August 2009

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2009

Journal of Hematopathology listed in PubMed!

Transformation of B cell lymphoma to histiocytic sarcoma: somatic mutations of PAX-5 gene with loss of expression cannot explain transdifferentiation

Recent advances in bone marrow biopsy pathology

Carcinoma and multiple lymphomas in one patient: establishing the diagnoses and analyzing risk factors

UK-based real-time lymphoproliferative disorder diagnostic service to improve the management of patients in Ghana

Myelofibrosis involving lymph node: a novel cytogenetic abnormality in a mimicker of mesenchymal neoplasm